Credit Agricole’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,000
Closed -$17K 593
2019
Q4
$17K Hold
2,000
﹤0.01% 372
2019
Q3
$18K Hold
2,000
﹤0.01% 429
2019
Q2
$22K Sell
2,000
-80,000
-98% -$851K ﹤0.01% 417
2019
Q1
$783K Buy
82,000
+80,000
+4,000% +$817K 0.04% 279
2018
Q4
$23K Hold
2,000
﹤0.01% 418
2018
Q3
$34K Hold
2,000
﹤0.01% 388
2018
Q2
$28K Buy
+2,000
New +$33.2K ﹤0.01% 353
2017
Q2
Sell
-111,456
Closed -$23M 1562
2017
Q1
$23M Buy
+111,456
New +$447K 0.07% 321

Other funds holding SGMO

Credit Agricole's SGMO Position: Q1 2020 in Review

Credit Agricole sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2020, closing a stake of 2,000 shares — an estimated $17K sold.

Credit Agricole first reported a position in SGMO in Q1 2017 and held it in 8 quarters. The position peaked at $23M in Q1 2017. 190 funds tracked by Wall St. Rank hold SGMO as of Q1 2020.

  • Credit Agricole reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2020 after selling out during the quarter.
  • Credit Agricole sold 2,000 SANGAMO THERAPEUTICS INC shares in Q1 2020, an estimated $17K.
  • Credit Agricole first reported a position in SANGAMO THERAPEUTICS INC in Q1 2017 and held it in 8 quarters.
  • Credit Agricole's SANGAMO THERAPEUTICS INC position peaked at $23M in Q1 2017.
  • 190 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2020.

Based on Credit Agricole's 13F filing for Q1 2020, filed 14 May 2020.